Literature DB >> 7690150

Global comparison of radiation and chemotherapy dose-response curves with a test for interaction.

M J Lindstrom1, K A Kunugi, T J Kinsella.   

Abstract

In the analysis of the effects of radiation or drugs on clonogenic survival data of mammalian cells, it is often advantageous to compare entire dose-response curves generated under different experimental conditions rather than to conduct single-dose comparisons. We propose a two-stage method for the global comparison of such curves. The first stage consists of individual fits of a flexible model to the dose-response sequences. The second stage treats the fitted coefficients as data and analyzes them jointly using a multivariate analysis of variance. For dose-response models of the type commonly used in the analysis of clonogenic survival data, this method allows the definition of a statistical test for interaction among treatments. That is, a test that the combination of agents produces a dose-response curve which is not what would be expected if the agents were acting multiplicatively (additively in the log cell survival scale). Analyses of cell survival curves by this method for experiments on iododeoxyuridine-mediated radiosensitization and on chemosensitization of bleomycin cytotoxicity in a human bladder cancer cell line (647V) are presented.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690150

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  11 in total

1.  Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.

Authors:  Meredith A Morgan; Leslie A Parsels; Lili Zhao; Joshua D Parsels; Mary A Davis; Maria C Hassan; Sankari Arumugarajah; Linda Hylander-Gans; Deborah Morosini; Diane M Simeone; Christine E Canman; Daniel P Normolle; Sonya D Zabludoff; Jonathan Maybaum; Theodore S Lawrence
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  Deoxynucleoside salvage facilitates DNA repair during ribonucleotide reductase blockade in human cervical cancers.

Authors:  Charles A Kunos; Gina Ferris; Natalie Pyatka; John Pink; Tomas Radivoyevitch
Journal:  Radiat Res       Date:  2011-07-14       Impact factor: 2.841

3.  Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1.

Authors:  Sean Vance; Erqi Liu; Lili Zhao; Joshua D Parsels; Leslie A Parsels; Jeffery L Brown; Jonathan Maybaum; Theodore S Lawrence; Meredith A Morgan
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

4.  Azidothymidine enhances fluorodeoxyuridine-mediated radiosensitization.

Authors:  Chang-Ming Chen; Monika Johnson; Brian J Smith; Ken Dornfeld
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

5.  Ribonucleotide reductase inhibition enhances chemoradiosensitivity of human cervical cancers.

Authors:  Charles A Kunos; Tomas Radivoyevitch; John Pink; Song-Mao Chiu; Tammy Stefan; James Jacobberger; Timothy J Kinsella
Journal:  Radiat Res       Date:  2010-09-10       Impact factor: 2.841

6.  Radiosensitization of human cervical cancer cells by inhibiting ribonucleotide reductase: enhanced radiation response at low-dose rates.

Authors:  Charles A Kunos; Valdir C Colussi; John Pink; Tomas Radivoyevitch; Nancy L Oleinick
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-04       Impact factor: 7.038

Review 7.  The application of 5-bromodeoxyuridine in the management of CNS tumors.

Authors:  A Freese; D O'Rourke; K Judy; M J O'Connor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein.

Authors:  Charles A Kunos; Song-mao Chiu; John Pink; Timothy J Kinsella
Journal:  Radiat Res       Date:  2009-12       Impact factor: 2.841

9.  4-Hydroxytamoxifen, an active metabolite of tamoxifen, does not alter the radiation sensitivity of MCF-7 breast carcinoma cells irradiated in vitro.

Authors:  J N Sarkaria; E M Miller; C J Parker; V C Jordan; R T Mulcahy
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Differences in Phosphorylated Histone H2AX Foci Formation and Removal of Cells Exposed to Low and High Linear Energy Transfer Radiation.

Authors:  Thomas Ernst Schmid; Olga Zlobinskaya; Gabriele Multhoff
Journal:  Curr Genomics       Date:  2012-09       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.